Cargando…
Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive co...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728361/ https://www.ncbi.nlm.nih.gov/pubmed/23936062 http://dx.doi.org/10.1371/journal.pone.0069643 |
_version_ | 1782278850375319552 |
---|---|
author | Li, Rutian Wu, Wei Liu, Qin Wu, Puyuan Xie, Li Zhu, Zhenshu Yang, Mi Qian, Xiaoping Ding, Yin Yu, Lixia Jiang, Xiqun Guan, Wenxian Liu, Baorui |
author_facet | Li, Rutian Wu, Wei Liu, Qin Wu, Puyuan Xie, Li Zhu, Zhenshu Yang, Mi Qian, Xiaoping Ding, Yin Yu, Lixia Jiang, Xiqun Guan, Wenxian Liu, Baorui |
author_sort | Li, Rutian |
collection | PubMed |
description | AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. MATERIALS AND METHODS: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. RESULTS: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. CONCLUSION: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed. |
format | Online Article Text |
id | pubmed-3728361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37283612013-08-09 Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles Li, Rutian Wu, Wei Liu, Qin Wu, Puyuan Xie, Li Zhu, Zhenshu Yang, Mi Qian, Xiaoping Ding, Yin Yu, Lixia Jiang, Xiqun Guan, Wenxian Liu, Baorui PLoS One Research Article AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. MATERIALS AND METHODS: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. RESULTS: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. CONCLUSION: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed. Public Library of Science 2013-07-30 /pmc/articles/PMC3728361/ /pubmed/23936062 http://dx.doi.org/10.1371/journal.pone.0069643 Text en © 2013 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Li, Rutian Wu, Wei Liu, Qin Wu, Puyuan Xie, Li Zhu, Zhenshu Yang, Mi Qian, Xiaoping Ding, Yin Yu, Lixia Jiang, Xiqun Guan, Wenxian Liu, Baorui Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title | Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title_full | Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title_fullStr | Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title_full_unstemmed | Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title_short | Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles |
title_sort | intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728361/ https://www.ncbi.nlm.nih.gov/pubmed/23936062 http://dx.doi.org/10.1371/journal.pone.0069643 |
work_keys_str_mv | AT lirutian intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT wuwei intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT liuqin intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT wupuyuan intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT xieli intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT zhuzhenshu intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT yangmi intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT qianxiaoping intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT dingyin intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT yulixia intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT jiangxiqun intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT guanwenxian intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles AT liubaorui intelligentlytargeteddrugdeliveryandenhancedantitumoreffectbygelatinaseresponsivenanoparticles |